<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2004-02-16" modified="2016-04-13" version="155">
<accession>P60484</accession>
<accession>B2R904</accession>
<accession>F2YHV0</accession>
<accession>O00633</accession>
<accession>O02679</accession>
<accession>Q6ICT7</accession>
<name>PTEN_HUMAN</name>
<protein>
<recommendedName>
<fullName>Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN</fullName>
<ecNumber>3.1.3.16</ecNumber>
<ecNumber>3.1.3.48</ecNumber>
<ecNumber>3.1.3.67</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Mutated in multiple advanced cancers 1</fullName>
</alternativeName>
<alternativeName>
<fullName>Phosphatase and tensin homolog</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">PTEN</name>
<name type="synonym">MMAC1</name>
<name type="synonym">TEP1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="Cancer Res." volume="57" first="2124" last="2129">
<title>TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta.</title>
<authorList>
<person name="Li D.M."/>
<person name="Sun H."/>
</authorList>
<dbReference type="PubMed" id="9187108"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INDUCTION</scope>
<source>
<tissue>Epithelium</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="Nat. Genet." volume="15" first="356" last="363">
<title>Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.</title>
<authorList>
<person name="Steck P.A."/>
<person name="Pershouse M.A."/>
<person name="Jasser S.A."/>
<person name="Lin H."/>
<person name="Yung W.K.A."/>
<person name="Ligon A.H."/>
<person name="Langford L.A."/>
<person name="Baumgard M.L."/>
<person name="Hattier T."/>
<person name="Davis T."/>
<person name="Frye C."/>
<person name="Hu R."/>
<person name="Swedlund B."/>
<person name="Teng D.H.-F."/>
<person name="Tavtigian S.V."/>
</authorList>
<dbReference type="PubMed" id="9090379"/>
<dbReference type="DOI" id="10.1038/ng0497-356"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANTS GLIOMA SER-15; GLU-36; ARG-42; TRP-57 AND THR-319 DEL</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1997" name="Science" volume="275" first="1943" last="1947">
<title>PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.</title>
<authorList>
<person name="Li J."/>
<person name="Yen C."/>
<person name="Liaw D."/>
<person name="Podsypanina K."/>
<person name="Bose S."/>
<person name="Wang S.I."/>
<person name="Puc J."/>
<person name="Miliaresis C."/>
<person name="Rodgers L."/>
<person name="McCombie R."/>
<person name="Bigner S.H."/>
<person name="Giovanella B.C."/>
<person name="Ittmann M."/>
<person name="Tycko B."/>
<person name="Hibshoosh H."/>
<person name="Wigler M.H."/>
<person name="Parsons R."/>
</authorList>
<dbReference type="PubMed" id="9072974"/>
<dbReference type="DOI" id="10.1126/science.275.5308.1943"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANTS GLIOBLASTOMA ARG-129 AND PROSTATE CANCER LEU-134</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2000" name="Br. J. Cancer" volume="82" first="1671" last="1676">
<title>The expression profile for the tumour suppressor gene PTEN and associated polymorphic markers.</title>
<authorList>
<person name="Hamilton J.A."/>
<person name="Stewart L.M.D."/>
<person name="Ajayi L."/>
<person name="Gray I.C."/>
<person name="Gray N.E."/>
<person name="Roberts K.G."/>
<person name="Watson G.J."/>
<person name="Kaisary A.V."/>
<person name="Snary D."/>
</authorList>
<dbReference type="PubMed" id="10817502"/>
<dbReference type="DOI" id="10.1054/bjoc.2000.1211"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="1997-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Wang S."/>
<person name="Li J."/>
<person name="Liaw D."/>
<person name="Bose S."/>
<person name="Podsypanina K."/>
<person name="Parsons R."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="1998-05" db="EMBL/GenBank/DDBJ databases">
<title>Genomic sequence of PTEN/MMAC1.</title>
<authorList>
<person name="Jensen K."/>
<person name="de la Bastide M."/>
<person name="Parsons R."/>
<person name="Parnell L.D."/>
<person name="Dedhia N."/>
<person name="Gottesman T."/>
<person name="Gnoj L."/>
<person name="Kaplan N."/>
<person name="Lodhi M."/>
<person name="Johnson A.F."/>
<person name="Shohdy N."/>
<person name="Hasegawa A."/>
<person name="Haberman K."/>
<person name="Huang E.N."/>
<person name="Schutz K."/>
<person name="Calma C."/>
<person name="Granat S."/>
<person name="Wigler M.H."/>
<person name="McCombie W.R."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2011-01" db="EMBL/GenBank/DDBJ databases">
<title>Homo sapiens phosphatase and tensin homolog mRNA splicing variants.</title>
<authorList>
<person name="Yang C.-W."/>
<person name="Hsu Y.-F."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
</reference>
<reference key="8">
<citation type="submission" date="2004-05" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201).</title>
<authorList>
<person name="Ebert L."/>
<person name="Schick M."/>
<person name="Neubert P."/>
<person name="Schatten R."/>
<person name="Henze S."/>
<person name="Korn B."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Spleen</tissue>
</source>
</reference>
<reference key="10">
<citation type="submission" date="2005-05" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT LEU-290</scope>
</reference>
<reference key="11">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="1997" name="Proc. Natl. Acad. Sci. U.S.A." volume="94" first="9052" last="9057">
<title>P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase.</title>
<authorList>
<person name="Myers M.P."/>
<person name="Stolarov J.P."/>
<person name="Eng C."/>
<person name="Li J."/>
<person name="Wang S.I."/>
<person name="Wigler M.H."/>
<person name="Parsons R."/>
<person name="Tonks N.K."/>
</authorList>
<dbReference type="PubMed" id="9256433"/>
<dbReference type="DOI" id="10.1073/pnas.94.17.9052"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>CHARACTERIZATION OF VARIANTS GLIOMA TRP-57; ENDOMETRIAL CANCER TYR-123; GLIOBLASTOMA ARG-129; CWS1 ARG-129; PROSTATE CANCER LEU-134; GLIOBLASTOMA ARG-165; BREAST CANCER PRO-167 AND BZ ARG-170</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="13375" last="13378">
<title>The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.</title>
<authorList>
<person name="Maehama T."/>
<person name="Dixon J.E."/>
</authorList>
<dbReference type="PubMed" id="9593664"/>
<dbReference type="DOI" id="10.1074/jbc.273.22.13375"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1998" name="Proc. Natl. Acad. Sci. U.S.A." volume="95" first="13513" last="13518">
<title>The lipid phosphatase activity of PTEN is critical for its tumor suppressor function.</title>
<authorList>
<person name="Myers M.P."/>
<person name="Pass I."/>
<person name="Batty I.H."/>
<person name="Van der Kaay J."/>
<person name="Stolarov J.P."/>
<person name="Hemmings B.A."/>
<person name="Wigler M.H."/>
<person name="Downes C.P."/>
<person name="Tonks N.K."/>
</authorList>
<dbReference type="PubMed" id="9811831"/>
<dbReference type="DOI" id="10.1073/pnas.95.23.13513"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>MUTAGENESIS OF ARG-130</scope>
<scope>CHARACTERIZATION OF VARIANTS CWS1 SER-124 AND CWS1 GLU-129</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1998" name="Science" volume="280" first="1614" last="1617">
<title>Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN.</title>
<authorList>
<person name="Tamura M."/>
<person name="Gu J."/>
<person name="Matsumoto K."/>
<person name="Aota S."/>
<person name="Parsons R."/>
<person name="Yamada K.M."/>
</authorList>
<dbReference type="PubMed" id="9616126"/>
<dbReference type="DOI" id="10.1126/science.280.5369.1614"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF ASP-92 AND CYS-124</scope>
<scope>CHARACTERIZATION OF VARIANT GLU-129</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1999" name="Proc. Natl. Acad. Sci. U.S.A." volume="96" first="10182" last="10187">
<title>The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region.</title>
<authorList>
<person name="Georgescu M.-M."/>
<person name="Kirsch K.H."/>
<person name="Akagi T."/>
<person name="Shishido T."/>
<person name="Hanafusa H."/>
</authorList>
<dbReference type="PubMed" id="10468583"/>
<dbReference type="DOI" id="10.1073/pnas.96.18.10182"/>
</citation>
<scope>FUNCTION</scope>
<scope>DOMAIN</scope>
<scope>CHARACTERIZATION OF VARIANTS THR-319 DEL; GLN-345 AND ILE-348</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2000" name="Cancer Res." volume="60" first="35" last="37">
<title>Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding.</title>
<authorList>
<person name="Adey N.B."/>
<person name="Huang L."/>
<person name="Ormonde P.A."/>
<person name="Baumgard M.L."/>
<person name="Pero R."/>
<person name="Byreddy D.V."/>
<person name="Tavtigian S.V."/>
<person name="Bartel P.L."/>
</authorList>
<dbReference type="PubMed" id="10646847"/>
</citation>
<scope>INTERACTION WITH DLG1 AND MAST2</scope>
<scope>PHOSPHORYLATION AT THR-401</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="21477" last="21485">
<title>Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase.</title>
<authorList>
<person name="Wu Y."/>
<person name="Dowbenko D."/>
<person name="Spencer S."/>
<person name="Laura R."/>
<person name="Lee J."/>
<person name="Gu Q."/>
<person name="Lasky L.A."/>
</authorList>
<dbReference type="PubMed" id="10748157"/>
<dbReference type="DOI" id="10.1074/jbc.M909741199"/>
</citation>
<scope>INTERACTION WITH MAGI3</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="4233" last="4238">
<title>Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2.</title>
<authorList>
<person name="Wu X."/>
<person name="Hepner K."/>
<person name="Castelino-Prabhu S."/>
<person name="Do D."/>
<person name="Kaye M.B."/>
<person name="Yuan X.-J."/>
<person name="Wood J."/>
<person name="Ross C."/>
<person name="Sawyers C.L."/>
<person name="Whang Y.E."/>
</authorList>
<dbReference type="PubMed" id="10760291"/>
<dbReference type="DOI" id="10.1073/pnas.97.8.4233"/>
</citation>
<scope>INTERACTION WITH AIP1</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="993" last="998">
<title>The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation.</title>
<authorList>
<person name="Torres J."/>
<person name="Pulido R."/>
</authorList>
<dbReference type="PubMed" id="11035045"/>
<dbReference type="DOI" id="10.1074/jbc.M009134200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-370; SER-380; THR-382; THR-383 AND SER-385</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="48627" last="48630">
<title>Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex.</title>
<authorList>
<person name="Vazquez F."/>
<person name="Grossman S.R."/>
<person name="Takahashi Y."/>
<person name="Rokas M.V."/>
<person name="Nakamura N."/>
<person name="Sellers W.R."/>
</authorList>
<dbReference type="PubMed" id="11707428"/>
<dbReference type="DOI" id="10.1074/jbc.C100556200"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH AIP1</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2002" name="FEBS Lett." volume="528" first="145" last="153">
<title>Direct identification of PTEN phosphorylation sites.</title>
<authorList>
<person name="Miller S."/>
<person name="Lou D."/>
<person name="Seldin D."/>
<person name="Lane W."/>
<person name="Neel B."/>
</authorList>
<dbReference type="PubMed" id="12297295"/>
<dbReference type="DOI" id="10.1016/S0014-5793(02)03274-X"/>
</citation>
<scope>PHOSPHORYLATION AT THR-366; SER-370 AND SER-385</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2005" name="Hum. Mol. Genet." volume="14" first="2209" last="2219">
<title>LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes.</title>
<authorList>
<person name="Mehenni H."/>
<person name="Lin-Marq N."/>
<person name="Buchet-Poyau K."/>
<person name="Reymond A."/>
<person name="Collart M.A."/>
<person name="Picard D."/>
<person name="Antonarakis S.E."/>
</authorList>
<dbReference type="PubMed" id="15987703"/>
<dbReference type="DOI" id="10.1093/hmg/ddi225"/>
</citation>
<scope>INTERACTION WITH STK11</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION BY STK11</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="28936" last="28943">
<title>Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases.</title>
<authorList>
<person name="Valiente M."/>
<person name="Andres-Pons A."/>
<person name="Gomar B."/>
<person name="Torres J."/>
<person name="Gil A."/>
<person name="Tapparel C."/>
<person name="Antonarakis S.E."/>
<person name="Pulido R."/>
</authorList>
<dbReference type="PubMed" id="15951562"/>
<dbReference type="DOI" id="10.1074/jbc.M504761200"/>
</citation>
<scope>INTERACTION WITH MAGI2; MAGI3; MAST1; MAST2 AND MAST3</scope>
<scope>MUTAGENESIS OF VAL-403</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2007" name="Cell" volume="128" first="129" last="139">
<title>NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN.</title>
<authorList>
<person name="Wang X."/>
<person name="Trotman L.C."/>
<person name="Koppie T."/>
<person name="Alimonti A."/>
<person name="Chen Z."/>
<person name="Gao Z."/>
<person name="Wang J."/>
<person name="Erdjument-Bromage H."/>
<person name="Tempst P."/>
<person name="Cordon-Cardo C."/>
<person name="Pandolfi P.P."/>
<person name="Jiang X."/>
</authorList>
<dbReference type="PubMed" id="17218260"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.11.039"/>
</citation>
<scope>INTERACTION WITH NEDD4</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2008" name="Nature" volume="455" first="813" last="817">
<title>The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network.</title>
<authorList>
<person name="Song M.S."/>
<person name="Salmena L."/>
<person name="Carracedo A."/>
<person name="Egia A."/>
<person name="Lo-Coco F."/>
<person name="Teruya-Feldstein J."/>
<person name="Pandolfi P.P."/>
</authorList>
<dbReference type="PubMed" id="18716620"/>
<dbReference type="DOI" id="10.1038/nature07290"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH USP7</scope>
<scope>UBIQUITINATION AT LYS-13 AND LYS-289</scope>
<scope>DEUBIQUITINATION BY USP7</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-13 AND LYS-289</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2009" name="Cancer Cell" volume="15" first="304" last="314">
<title>Rak functions as a tumor suppressor by regulating PTEN protein stability and function.</title>
<authorList>
<person name="Yim E.-K."/>
<person name="Peng G."/>
<person name="Dai H."/>
<person name="Hu R."/>
<person name="Li K."/>
<person name="Lu Y."/>
<person name="Mills G.B."/>
<person name="Meric-Bernstam F."/>
<person name="Hennessy B.T."/>
<person name="Craven R.J."/>
<person name="Lin S.-Y."/>
</authorList>
<dbReference type="PubMed" id="19345329"/>
<dbReference type="DOI" id="10.1016/j.ccr.2009.02.012"/>
</citation>
<scope>INTERACTION WITH FRK</scope>
<scope>PHOSPHORYLATION AT TYR-336</scope>
<scope>MUTAGENESIS OF TYR-336</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="20462" last="20466">
<title>X-linked inhibitor of apoptosis protein (XIAP) regulates PTEN ubiquitination, content, and compartmentalization.</title>
<authorList>
<person name="Van Themsche C."/>
<person name="Leblanc V."/>
<person name="Parent S."/>
<person name="Asselin E."/>
</authorList>
<dbReference type="PubMed" id="19473982"/>
<dbReference type="DOI" id="10.1074/jbc.C109.009522"/>
</citation>
<scope>UBIQUITINATION BY XIAP/BIRC4</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH XIAP/BIRC4</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="39935" last="39942">
<title>Regulation of PTEN stability and activity by Plk3.</title>
<authorList>
<person name="Xu D."/>
<person name="Yao Y."/>
<person name="Jiang X."/>
<person name="Lu L."/>
<person name="Dai W."/>
</authorList>
<dbReference type="PubMed" id="20940307"/>
<dbReference type="DOI" id="10.1074/jbc.M110.166462"/>
</citation>
<scope>PHOSPHORYLATION AT THR-366 AND SER-370</scope>
<scope>MUTAGENESIS OF THR-366 AND SER-370</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="11429" last="11434">
<title>Regulation of PTEN/Akt and MAP kinase signaling pathways by the ubiquitin ligase activators Ndfip1 and Ndfip2.</title>
<authorList>
<person name="Mund T."/>
<person name="Pelham H.R."/>
</authorList>
<dbReference type="PubMed" id="20534535"/>
<dbReference type="DOI" id="10.1073/pnas.0911714107"/>
</citation>
<scope>INTERACTION WITH NDFIP1 AND NDFIP2</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2012" name="Genes Dev." volume="26" first="176" last="189">
<title>IGF2BP1 promotes cell migration by regulating MK5 and PTEN signaling.</title>
<authorList>
<person name="Stohr N."/>
<person name="Kohn M."/>
<person name="Lederer M."/>
<person name="Glass M."/>
<person name="Reinke C."/>
<person name="Singer R.H."/>
<person name="Huttelmaier S."/>
</authorList>
<dbReference type="PubMed" id="22279049"/>
<dbReference type="DOI" id="10.1101/gad.177642.111"/>
</citation>
<scope>FUNCTION IN CELL MIGRATION</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT THR-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2013" name="Science" volume="341" first="399" last="402">
<title>A secreted PTEN phosphatase that enters cells to alter signaling and survival.</title>
<authorList>
<person name="Hopkins B.D."/>
<person name="Fine B."/>
<person name="Steinbach N."/>
<person name="Dendy M."/>
<person name="Rapp Z."/>
<person name="Shaw J."/>
<person name="Pappas K."/>
<person name="Yu J.S."/>
<person name="Hodakoski C."/>
<person name="Mense S."/>
<person name="Klein J."/>
<person name="Pegno S."/>
<person name="Sulis M.L."/>
<person name="Goldstein H."/>
<person name="Amendolara B."/>
<person name="Lei L."/>
<person name="Maurer M."/>
<person name="Bruce J."/>
<person name="Canoll P."/>
<person name="Hibshoosh H."/>
<person name="Parsons R."/>
</authorList>
<dbReference type="PubMed" id="23744781"/>
<dbReference type="DOI" id="10.1126/science.1234907"/>
</citation>
<scope>ALTERNATIVE INITIATION (ISOFORM ALPHA)</scope>
<scope>CTG START CODON</scope>
<scope>FUNCTION (ISOFORM ALPHA)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM ALPHA)</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2014" name="Cell Metab." volume="19" first="836" last="848">
<title>PTENalpha, a PTEN isoform translated through alternative initiation, regulates mitochondrial function and energy metabolism.</title>
<authorList>
<person name="Liang H."/>
<person name="He S."/>
<person name="Yang J."/>
<person name="Jia X."/>
<person name="Wang P."/>
<person name="Chen X."/>
<person name="Zhang Z."/>
<person name="Zou X."/>
<person name="McNutt M.A."/>
<person name="Shen W.H."/>
<person name="Yin Y."/>
</authorList>
<dbReference type="PubMed" id="24768297"/>
<dbReference type="DOI" id="10.1016/j.cmet.2014.03.023"/>
</citation>
<scope>ALTERNATIVE INITIATION (ISOFORM ALPHA)</scope>
<scope>CTG START CODON</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM ALPHA)</scope>
<scope>MUTAGENESIS OF MET-1</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-366</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="38">
<citation type="journal article" date="1999" name="Cell" volume="99" first="323" last="334">
<title>Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association.</title>
<authorList>
<person name="Lee J.-O."/>
<person name="Yang H."/>
<person name="Georgescu M.-M."/>
<person name="Di Cristofano A."/>
<person name="Maehama T."/>
<person name="Shi Y."/>
<person name="Dixon J.E."/>
<person name="Pandolfi P."/>
<person name="Pavletich N.P."/>
</authorList>
<dbReference type="PubMed" id="10555148"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)81663-3"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 8-353 IN COMPLEX WITH L(+)-TARTRATE</scope>
<scope>SUBUNIT</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF ASP-92; HIS-93; LYS-125; LYS-128; THR-167; GLN-171; 263-LYS--ALA-269 AND 327-LYS--ALA-335</scope>
</reference>
<reference key="39">
<citation type="journal article" date="1997" name="Am. J. Hum. Genet." volume="61" first="1036" last="1043">
<title>The role of MMAC1 mutations in early-onset breast cancer: causative in association with Cowden syndrome and excluded in BRCA1-negative cases.</title>
<authorList>
<person name="Tsou H.C."/>
<person name="Teng D.H.-F."/>
<person name="Ping X.L."/>
<person name="Brancolini V."/>
<person name="Davis T."/>
<person name="Hu R."/>
<person name="Xie X.X."/>
<person name="Gruener A.C."/>
<person name="Schrager C.A."/>
<person name="Christiano A.M."/>
<person name="Eng C."/>
<person name="Steck P."/>
<person name="Ott J."/>
<person name="Tavtigian S.V."/>
<person name="Peacocke M."/>
</authorList>
<dbReference type="PubMed" id="9345101"/>
<dbReference type="DOI" id="10.1086/301607"/>
</citation>
<scope>VARIANT CWS1 ASN-137 INS</scope>
</reference>
<reference key="40">
<citation type="journal article" date="1997" name="Am. J. Hum. Genet." volume="61" first="1254" last="1260">
<title>Inherited mutations in PTEN that are associated with breast cancer, Cowden disease, and juvenile polyposis.</title>
<authorList>
<person name="Lynch E.D."/>
<person name="Ostermeyer E.A."/>
<person name="Lee M.K."/>
<person name="Arena J.F."/>
<person name="Ji H."/>
<person name="Dann J."/>
<person name="Swisshelm K."/>
<person name="Suchard D."/>
<person name="MacLeod P.M."/>
<person name="Kvinnsland S."/>
<person name="Gjertsen B.T."/>
<person name="Heimdal K."/>
<person name="Lubs H."/>
<person name="Moeller P."/>
<person name="King M.-C."/>
</authorList>
<dbReference type="PubMed" id="9399897"/>
<dbReference type="DOI" id="10.1086/301639"/>
</citation>
<scope>VARIANTS CWS1 GLU-343 AND LEU-347</scope>
</reference>
<reference key="41">
<citation type="journal article" date="1997" name="Cancer Res." volume="57" first="4183" last="4186">
<title>Somatic mutations of PTEN in glioblastoma multiforme.</title>
<authorList>
<person name="Wang S.I."/>
<person name="Puc J."/>
<person name="Li J."/>
<person name="Bruce J.N."/>
<person name="Cairns P."/>
<person name="Sidransky D."/>
<person name="Parsons R."/>
</authorList>
<dbReference type="PubMed" id="9331071"/>
</citation>
<scope>VARIANTS GLIOBLASTOMA TYR-107; PRO-121; ARG-129; ARG-165 AND GLN-345</scope>
</reference>
<reference key="42">
<citation type="journal article" date="1997" name="Hum. Mol. Genet." volume="6" first="1383" last="1387">
<title>Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease.</title>
<authorList>
<person name="Nelen M.R."/>
<person name="van Staveren W.C.G."/>
<person name="Peeters E.A.J."/>
<person name="Ben-Hassel M."/>
<person name="Gorlin R.J."/>
<person name="Hamm H."/>
<person name="Lindboe C.F."/>
<person name="Fryns J.-P."/>
<person name="Sijmons R.H."/>
<person name="Woods D.G."/>
<person name="Mariman E.C.M."/>
<person name="Padberg G.W."/>
<person name="Kremer H."/>
</authorList>
<dbReference type="PubMed" id="9259288"/>
<dbReference type="DOI" id="10.1093/hmg/6.8.1383"/>
</citation>
<scope>VARIANTS CWS1 ARG-123 AND ARG-124</scope>
</reference>
<reference key="43">
<citation type="journal article" date="1997" name="Nat. Genet." volume="16" first="64" last="67">
<title>Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.</title>
<authorList>
<person name="Liaw D."/>
<person name="Marsh D.J."/>
<person name="Li J."/>
<person name="Dahia P.L.M."/>
<person name="Wang S.I."/>
<person name="Zheng Z."/>
<person name="Bose S."/>
<person name="Call K.M."/>
<person name="Tsou H.C."/>
<person name="Peacocke M."/>
<person name="Eng C."/>
<person name="Parsons R."/>
</authorList>
<dbReference type="PubMed" id="9140396"/>
<dbReference type="DOI" id="10.1038/ng0597-64"/>
</citation>
<scope>VARIANT CWS1 GLU-129</scope>
</reference>
<reference key="44">
<citation type="journal article" date="1997" name="Nat. Genet." volume="16" first="333" last="334">
<title>Germline mutations in PTEN are present in Bannayan-Zonana syndrome.</title>
<authorList>
<person name="Marsh D.J."/>
<person name="Dahia P.L.M."/>
<person name="Zheng Z."/>
<person name="Liaw D."/>
<person name="Parsons R."/>
<person name="Gorlin R.J."/>
<person name="Eng C."/>
</authorList>
<dbReference type="PubMed" id="9241266"/>
<dbReference type="DOI" id="10.1038/ng0897-333"/>
</citation>
<scope>VARIANT BRRS ARG-170</scope>
</reference>
<reference key="45">
<citation type="journal article" date="1998" name="Cancer Res." volume="58" first="2500" last="2503">
<title>Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias.</title>
<authorList>
<person name="Maxwell G.L."/>
<person name="Risinger J.I."/>
<person name="Gumbs C."/>
<person name="Shaw H."/>
<person name="Bentley R.C."/>
<person name="Barrett J.C."/>
<person name="Berchuck A."/>
<person name="Futreal P.A."/>
</authorList>
<dbReference type="PubMed" id="9635567"/>
</citation>
<scope>VARIANTS ENDOMETRIAL HYPERPLASIA ARG-36; LEU-130; CYS-173; ALA-191 AND ILE-348</scope>
</reference>
<reference key="46">
<citation type="journal article" date="1998" name="Gastroenterology" volume="115" first="1084" last="1089">
<title>Mutational abrogation of the PTEN/MMAC1 gene in gastrointestinal polyps in patients with Cowden disease.</title>
<authorList>
<person name="Chi S.-G."/>
<person name="Kim H.-J."/>
<person name="Park B.-J."/>
<person name="Min H.-J."/>
<person name="Park J.-H."/>
<person name="Kim Y.-W."/>
<person name="Dong S.-H."/>
<person name="Kim B.-H."/>
<person name="Lee J.-I."/>
<person name="Chang Y.-W."/>
<person name="Chang R."/>
<person name="Kim W.-K."/>
<person name="Yang M.-H."/>
</authorList>
<dbReference type="PubMed" id="9797362"/>
<dbReference type="DOI" id="10.1016/S0016-5085(98)70078-2"/>
</citation>
<scope>VARIANT CWS1 GLU-289</scope>
</reference>
<reference key="47">
<citation type="journal article" date="1998" name="Hum. Genet." volume="102" first="467" last="473">
<title>The genetic basis of Cowden's syndrome: three novel mutations in PTEN/MMAC1/TEP1.</title>
<authorList>
<person name="Tsou H.C."/>
<person name="Ping X.L."/>
<person name="Xie X.X."/>
<person name="Gruener A.C."/>
<person name="Zhang H."/>
<person name="Nini R."/>
<person name="Swisshelm K."/>
<person name="Sybert V."/>
<person name="Diamond T.M."/>
<person name="Sutphen R."/>
<person name="Peacocke M."/>
</authorList>
<dbReference type="PubMed" id="9600246"/>
<dbReference type="DOI" id="10.1007/s004390050723"/>
</citation>
<scope>VARIANTS CWS1 HIS-68 AND PRO-112</scope>
</reference>
<reference key="48">
<citation type="journal article" date="1998" name="Hum. Mol. Genet." volume="7" first="507" last="515">
<title>Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.</title>
<authorList>
<person name="Marsh D.J."/>
<person name="Coulon V."/>
<person name="Lunetta K.L."/>
<person name="Rocca-Serra P."/>
<person name="Dahia P.L.M."/>
<person name="Zheng Z."/>
<person name="Liaw D."/>
<person name="Caron S."/>
<person name="Duboue B."/>
<person name="Lin A.Y."/>
<person name="Richardson A.-L."/>
<person name="Bonnetblanc J.-M."/>
<person name="Bressieux J.-M."/>
<person name="Cabarrot-Moreau A."/>
<person name="Chompret A."/>
<person name="Demange L."/>
<person name="Eeles R.A."/>
<person name="Yahanda A.M."/>
<person name="Fearon E.R."/>
<person name="Fricker J.-P."/>
<person name="Gorlin R.J."/>
<person name="Hodgson S.V."/>
<person name="Huson S."/>
<person name="Lacombe D."/>
<person name="Leprat F."/>
<person name="Odent S."/>
<person name="Toulouse C."/>
<person name="Olopade O.I."/>
<person name="Sobol H."/>
<person name="Tishler S."/>
<person name="Woods C.G."/>
<person name="Robinson B.G."/>
<person name="Weber H.C."/>
<person name="Parsons R."/>
<person name="Peacocke M."/>
<person name="Longy M."/>
<person name="Eng C."/>
</authorList>
<dbReference type="PubMed" id="9467011"/>
<dbReference type="DOI" id="10.1093/hmg/7.3.507"/>
</citation>
<scope>VARIANTS CWS1 AND BRRS</scope>
</reference>
<reference key="49">
<citation type="journal article" date="1998" name="Int. J. Oncol." volume="13" first="665" last="668">
<title>Novel mutation of the PTEN gene in an Italian Cowden's disease kindred.</title>
<authorList>
<person name="Scala S."/>
<person name="Bruni P."/>
<person name="Lo Muzio L."/>
<person name="Mignogna M."/>
<person name="Viglietto G."/>
<person name="Fusco A."/>
</authorList>
<dbReference type="PubMed" id="9735393"/>
</citation>
<scope>VARIANT CWS1 TYR-136</scope>
</reference>
<reference key="50">
<citation type="journal article" date="1998" name="J. Med. Genet." volume="35" first="881" last="885">
<title>Germline PTEN mutations in Cowden syndrome-like families.</title>
<authorList>
<person name="Marsh D.J."/>
<person name="Dahia P.L.M."/>
<person name="Caron S."/>
<person name="Kum J.B."/>
<person name="Frayling I.M."/>
<person name="Tomlinson I.P.M."/>
<person name="Hughes K.S."/>
<person name="Eeles R.A."/>
<person name="Hodgson S.V."/>
<person name="Murday V.A."/>
<person name="Houlston R."/>
<person name="Eng C."/>
</authorList>
<dbReference type="PubMed" id="9832031"/>
<dbReference type="DOI" id="10.1136/jmg.35.11.881"/>
</citation>
<scope>VARIANT CWS1 PRO-70</scope>
</reference>
<reference key="51">
<citation type="journal article" date="1998" name="Nat. Genet." volume="18" first="12" last="14">
<title>PTEN germ-line mutations in juvenile polyposis coli.</title>
<authorList>
<person name="Olschwang S."/>
<person name="Serova-Sinilnikova O.M."/>
<person name="Lenoir G.M."/>
<person name="Thomas G."/>
</authorList>
<dbReference type="PubMed" id="9425889"/>
<dbReference type="DOI" id="10.1038/ng0198-12"/>
</citation>
<scope>VARIANT CWS1 ARG-35</scope>
</reference>
<reference key="52">
<citation type="journal article" date="1999" name="Am. J. Hum. Genet." volume="64" first="308" last="310">
<title>Variant manifestation of Cowden disease in Japan: hamartomatous polyposis of the digestive tract with mutation of the PTEN gene.</title>
<authorList>
<person name="Kurose K."/>
<person name="Araki T."/>
<person name="Matsunaka T."/>
<person name="Takada Y."/>
<person name="Emi M."/>
</authorList>
<dbReference type="PubMed" id="9915974"/>
<dbReference type="DOI" id="10.1086/302207"/>
</citation>
<scope>VARIANT CWS1 GLN-130</scope>
</reference>
<reference key="53">
<citation type="journal article" date="1999" name="Am. J. Med. Genet." volume="82" first="290" last="293">
<title>Severe Lhermitte-Duclos disease with unique germline mutation of PTEN.</title>
<authorList>
<person name="Sutphen R."/>
<person name="Diamond T.M."/>
<person name="Minton S.E."/>
<person name="Peacocke M."/>
<person name="Tsou H.C."/>
<person name="Root A.W."/>
</authorList>
<dbReference type="PubMed" id="10051160"/>
<dbReference type="DOI" id="10.1002/(SICI)1096-8628(19990212)82:4&lt;290::AID-AJMG3>3.0.CO;2-0"/>
</citation>
<scope>VARIANT CWS1/LDD PRO-112</scope>
</reference>
<reference key="54">
<citation type="journal article" date="1999" name="Eur. J. Hum. Genet." volume="7" first="267" last="273">
<title>Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations.</title>
<authorList>
<person name="Nelen M.R."/>
<person name="Kremer H."/>
<person name="Konings I.B.M."/>
<person name="Schoute F."/>
<person name="van Essen A.J."/>
<person name="Koch R."/>
<person name="Woods C.G."/>
<person name="Fryns J.-P."/>
<person name="Hamel B.C.J."/>
<person name="Hoefsloot L.H."/>
<person name="Peeters E.A.J."/>
<person name="Padberg G.W."/>
</authorList>
<dbReference type="PubMed" id="10234502"/>
<dbReference type="DOI" id="10.1038/sj.ejhg.5200289"/>
</citation>
<scope>VARIANTS CWS1 ILE-33 DEL; ARG-123; ARG-124 AND GLU-165</scope>
</reference>
<reference key="55">
<citation type="journal article" date="1999" name="Hum. Mol. Genet." volume="8" first="1461" last="1472">
<title>PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome.</title>
<authorList>
<person name="Marsh D.J."/>
<person name="Kum J.B."/>
<person name="Lunetta K.L."/>
<person name="Bennett M.J."/>
<person name="Gorlin R.J."/>
<person name="Ahmed S.F."/>
<person name="Bodurtha J."/>
<person name="Crowe C."/>
<person name="Curtis M.A."/>
<person name="Dasouki M."/>
<person name="Dunn T."/>
<person name="Feit H."/>
<person name="Geraghty M.T."/>
<person name="Graham J.M. Jr."/>
<person name="Hodgson S.V."/>
<person name="Hunter A."/>
<person name="Korf B.R."/>
<person name="Manchester D."/>
<person name="Miesfeldt S."/>
<person name="Murday V.A."/>
<person name="Nathanson K.L."/>
<person name="Parisi M."/>
<person name="Pober B."/>
<person name="Romano C."/>
<person name="Tolmie J.L."/>
<person name="Trembath R."/>
<person name="Winter R.M."/>
<person name="Zackai E.H."/>
<person name="Zori R.T."/>
<person name="Weng L.-P."/>
<person name="Dahia P.L.M."/>
<person name="Eng C."/>
</authorList>
<dbReference type="PubMed" id="10400993"/>
<dbReference type="DOI" id="10.1093/hmg/8.8.1461"/>
</citation>
<scope>VARIANTS BRRS ASP-34; HIS-68; TYR-105; VAL-135; ARG-170 AND LEU-246</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2000" name="Cancer Res." volume="60" first="3147" last="3151">
<title>Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay.</title>
<authorList>
<person name="Han S.-Y."/>
<person name="Kato H."/>
<person name="Kato S."/>
<person name="Suzuki T."/>
<person name="Shibata H."/>
<person name="Ishii S."/>
<person name="Shiiba K."/>
<person name="Matsuno S."/>
<person name="Kanamaru R."/>
<person name="Ishioka C."/>
</authorList>
<dbReference type="PubMed" id="10866302"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS ASN-10; CYS-16; GLU-20; SER-27; ARG-61; HIS-68; CWS1 TYR-71; CWS1 TYR-93; BRRS PHE-105; BRRS TYR-107; PRO-112; ARG-112; PRO-121; ARG-124; ARG-129; GLU-129; GLY-130; CWS1 LEU-130; GLN-130; ILE-133; LEU-134; TYR-136; CYS-155; ARG-165; ASN-170; ARG-170; CYS-173; HIS-173; PRO-173; ASN-174; PHE-227; CYS-251; GLU-289; GLY-331; VAL-341; ASN-342; GLU-343; GLN-345; LEU-347; GLY-369 AND ILE-401</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2000" name="J. Med. Genet." volume="37" first="336" last="341">
<title>Novel germline mutations in the PTEN tumour suppressor gene found in women with multiple cancers.</title>
<authorList>
<person name="De Vivo I."/>
<person name="Gertig D.M."/>
<person name="Nagase S."/>
<person name="Hankinson S.E."/>
<person name="O'Brien R."/>
<person name="Speizer F.E."/>
<person name="Parsons R."/>
<person name="Hunter D.J."/>
</authorList>
<dbReference type="PubMed" id="10807691"/>
<dbReference type="DOI" id="10.1136/jmg.37.5.336"/>
</citation>
<scope>VARIANTS MULTIPLE CANCERS LEU-119 AND LEU-158</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2000" name="J. Med. Genet." volume="37" first="653" last="657">
<title>Identification of PTEN mutations in metastatic melanoma specimens.</title>
<authorList>
<person name="Celebi J.T."/>
<person name="Shendrik I."/>
<person name="Silvers D.N."/>
<person name="Peacocke M."/>
</authorList>
<dbReference type="PubMed" id="10978354"/>
<dbReference type="DOI" id="10.1136/jmg.37.9.653"/>
</citation>
<scope>VARIANTS MALIGNANT MELANOMA ASN-19 AND ILE-217</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2001" name="Hum. Mol. Genet." volume="10" first="599" last="604">
<title>PTEN coordinates G1 arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model.</title>
<authorList>
<person name="Weng L.-P."/>
<person name="Brown J.L."/>
<person name="Eng C."/>
</authorList>
<dbReference type="PubMed" id="11230179"/>
<dbReference type="DOI" id="10.1093/hmg/10.6.599"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS CWS1 SER-124 AND GLU-129</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2001" name="J. Med. Genet." volume="38" first="820" last="823">
<title>A novel germline mutation of the PTEN gene in a patient with macrocephaly, ventricular dilatation, and features of VATER association.</title>
<authorList>
<person name="Reardon W."/>
<person name="Zhou X.-P."/>
<person name="Eng C."/>
</authorList>
<dbReference type="PubMed" id="11748304"/>
<dbReference type="DOI" id="10.1136/jmg.38.12.820"/>
</citation>
<scope>VARIANT VATER ASP-61</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2001" name="Neoplasia" volume="3" first="236" last="244">
<title>Rapid mutation scanning of genes associated with familial cancer syndromes using denaturing high-performance liquid chromatography.</title>
<authorList>
<person name="Marsh D.J."/>
<person name="Theodosopoulos G."/>
<person name="Howell V."/>
<person name="Richardson A.-L."/>
<person name="Benn D.E."/>
<person name="Proos A.L."/>
<person name="Eng C."/>
<person name="Robinson B.G."/>
</authorList>
<dbReference type="PubMed" id="11494117"/>
<dbReference type="DOI" id="10.1038/sj.neo.7900154"/>
</citation>
<scope>VARIANT CWS1 GLY-47</scope>
<scope>VARIANTS BRRS ASP-34; HIS-68; TYR-105; VAL-135 AND ARG-170</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2002" name="Br. J. Cancer" volume="86" first="1586" last="1591">
<title>A novel germline mutation of PTEN associated with brain tumours of multiple lineages.</title>
<authorList>
<person name="Staal F.J.T."/>
<person name="van der Luijt R.B."/>
<person name="Baert M.R.M."/>
<person name="van Drunen J."/>
<person name="van Bakel H."/>
<person name="Peters E."/>
<person name="de Valk I."/>
<person name="van Amstel H.K.P."/>
<person name="Taphoorn M.J.B."/>
<person name="Jansen G.H."/>
<person name="van Veelen C.W.M."/>
<person name="Burgering B."/>
<person name="Staal G.E.J."/>
</authorList>
<dbReference type="PubMed" id="12085208"/>
<dbReference type="DOI" id="10.1038/sj.bjc.6600206"/>
</citation>
<scope>VARIANT GLM2 GLN-234</scope>
<scope>CHARACTERIZATION OF VARIANT GLM2 GLN-234</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2002" name="Cancer Genet. Cytogenet." volume="132" first="20" last="24">
<title>Detection of new PTEN/MMAC1 mutations in head and neck squamous cell carcinomas with loss of chromosome 10.</title>
<authorList>
<person name="Poetsch M."/>
<person name="Lorenz G."/>
<person name="Kleist B."/>
</authorList>
<dbReference type="PubMed" id="11801303"/>
<dbReference type="DOI" id="10.1016/S0165-4608(01)00509-X"/>
</citation>
<scope>VARIANT HNSCC GLY-121</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2002" name="J. Med. Genet." volume="39" first="937" last="940">
<title>Germline mutation of the tumour suppressor PTEN in Proteus syndrome.</title>
<authorList>
<person name="Smith J.M."/>
<person name="Kirk E.P.E."/>
<person name="Theodosopoulos G."/>
<person name="Marshall G.M."/>
<person name="Walker J."/>
<person name="Rogers M."/>
<person name="Field M."/>
<person name="Brereton J.J."/>
<person name="Marsh D.J."/>
</authorList>
<dbReference type="PubMed" id="12471211"/>
<dbReference type="DOI" id="10.1136/jmg.39.12.937"/>
</citation>
<scope>DISCUSSION OF PTEN INVOLVEMENT IN PROTEUS SYNDROME</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2005" name="J. Med. Genet." volume="42" first="318" last="321">
<title>Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations.</title>
<authorList>
<person name="Butler M.G."/>
<person name="Dasouki M.J."/>
<person name="Zhou X.-P."/>
<person name="Talebizadeh Z."/>
<person name="Brown M."/>
<person name="Takahashi T.N."/>
<person name="Miles J.H."/>
<person name="Wang C.H."/>
<person name="Stratton R."/>
<person name="Pilarski R."/>
<person name="Eng C."/>
</authorList>
<dbReference type="PubMed" id="15805158"/>
<dbReference type="DOI" id="10.1136/jmg.2004.024646"/>
</citation>
<scope>VARIANTS MCEPHAS ARG-93; SER-241 AND GLY-252</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2007" name="Am. J. Hum. Genet." volume="80" first="938" last="947">
<title>Recurrent 10q22-q23 deletions: a genomic disorder on 10q associated with cognitive and behavioral abnormalities.</title>
<authorList>
<person name="Balciuniene J."/>
<person name="Feng N."/>
<person name="Iyadurai K."/>
<person name="Hirsch B."/>
<person name="Charnas L."/>
<person name="Bill B.R."/>
<person name="Easterday M.C."/>
<person name="Staaf J."/>
<person name="Oseth L."/>
<person name="Czapansky-Beilman D."/>
<person name="Avramopoulos D."/>
<person name="Thomas G.H."/>
<person name="Borg A."/>
<person name="Valle D."/>
<person name="Schimmenti L.A."/>
<person name="Selleck S.B."/>
</authorList>
<dbReference type="PubMed" id="17436248"/>
<dbReference type="DOI" id="10.1086/513607"/>
</citation>
<scope>INVOLVEMENT IN CHROMOSOME 10Q23 DELETION SYNDROME</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2006" name="Am. J. Med. Genet. A" volume="140" first="1472" last="1475">
<title>A germline PTEN mutation with manifestations of prenatal onset and verrucous epidermal nevus.</title>
<authorList>
<person name="Tekin M."/>
<person name="Hismi B.O."/>
<person name="Fitoz S."/>
<person name="Yalcinkaya F."/>
<person name="Ekim M."/>
<person name="Kansu A."/>
<person name="Ertem M."/>
<person name="Deda G."/>
<person name="Tutar E."/>
<person name="Arsan S."/>
<person name="Zhou X.-P."/>
<person name="Pilarski R."/>
<person name="Eng C."/>
<person name="Akar N."/>
</authorList>
<dbReference type="PubMed" id="16752378"/>
<dbReference type="DOI" id="10.1002/ajmg.a.31273"/>
</citation>
<scope>VARIANT VAL-132</scope>
</reference>
<comment type="function">
<text>Tumor suppressor. Acts as a dual-specificity protein phosphatase, dephosphorylating tyrosine-, serine- and threonine-phosphorylated proteins. Also acts as a lipid phosphatase, removing the phosphate in the D3 position of the inositol ring from phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3,4-diphosphate, phosphatidylinositol 3-phosphate and inositol 1,3,4,5-tetrakisphosphate with order of substrate preference in vitro PtdIns(3,4,5)P3 > PtdIns(3,4)P2 > PtdIns3P > Ins(1,3,4,5)P4. The lipid phosphatase activity is critical for its tumor suppressor function. Antagonizes the PI3K-AKT/PKB signaling pathway by dephosphorylating phosphoinositides and thereby modulating cell cycle progression and cell survival. The unphosphorylated form cooperates with AIP1 to suppress AKT1 activation. Dephosphorylates tyrosine-phosphorylated focal adhesion kinase and inhibits cell migration and integrin-mediated cell spreading and focal adhesion formation. Plays a role as a key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation. May be a negative regulator of insulin signaling and glucose metabolism in adipose tissue. The nuclear monoubiquitinated form possesses greater apoptotic potential, whereas the cytoplasmic nonubiquitinated form induces less tumor suppressive ability. In motile cells, suppresses the formation of lateral pseudopods and thereby promotes cell polarization and directed movement.</text>
</comment>
<comment type="function">
<text>Isoform alpha: Functional kinase, like isoform 1 it antagonizes the PI3K-AKT/PKB signaling pathway. Plays a role in mitochondrial energetic metabolism by promoting COX activity and ATP production, via collaboration with isoform 1 in increasing protein levels of PINK1.</text>
</comment>
<comment type="catalytic activity">
<text>Phosphatidylinositol 3,4,5-trisphosphate + H(2)O = phosphatidylinositol 4,5-bisphosphate + phosphate.</text>
</comment>
<comment type="catalytic activity">
<text>[a protein]-serine/threonine phosphate + H(2)O = [a protein]-serine/threonine + phosphate.</text>
</comment>
<comment type="catalytic activity">
<text>Protein tyrosine phosphate + H(2)O = protein tyrosine + phosphate.</text>
</comment>
<comment type="cofactor">
<cofactor>
<name>Mg(2+)</name>
<dbReference type="ChEBI" id="CHEBI:18420"/>
</cofactor>
</comment>
<comment type="subunit">
<text evidence="7 15 16 17 18 25 31 32 34 35 36 37 38">Monomer. The unphosphorylated form interacts with the second PDZ domain of AIP1 and with DLG1 and MAST2 in vitro. Interacts with MAGI2, MAGI3, MAST1 and MAST3, but neither with MAST4 nor with DLG5; interaction with MAGI2 increases protein stability. Interacts with NEDD4. Interacts with NDFIP1 and NDFIP2; in the presence of NEDD4 or ITCH, this interaction promotes PTEN ubiquitination. Interacts (via C2 domain) with FRK. Interacts with USP7; the interaction is direct. Interacts with ROCK1 (By similarity). Interacts with XIAP/BIRC4. Interacts with STK11; the interaction phosphorylates PTEN.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-696162"/>
<interactant intactId="EBI-696162"/>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-696162"/>
<interactant intactId="EBI-2341576">
<id>P35226</id>
<label>BMI1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-696162"/>
<interactant intactId="EBI-994813">
<id>P30260</id>
<label>CDC27</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-696162"/>
<interactant intactId="EBI-351394">
<id>Q16643</id>
<label>DBN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-696162"/>
<interactant intactId="EBI-389325">
<id>Q62696</id>
<label>Dlg1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-696162"/>
<interactant intactId="EBI-1383583">
<id>P42685</id>
<label>FRK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-696162"/>
<interactant intactId="EBI-696179">
<id>O88382</id>
<label>Magi2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-696162"/>
<interactant intactId="EBI-310506">
<id>Q5TCQ9</id>
<label>MAGI3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-696162"/>
<interactant intactId="EBI-696226">
<id>Q9JK71</id>
<label>Magi3</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-696162"/>
<interactant intactId="EBI-491771">
<id>Q9R1L5</id>
<label>Mast1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-696162"/>
<interactant intactId="EBI-493888">
<id>Q60592</id>
<label>Mast2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-696162"/>
<interactant intactId="EBI-311420">
<id>O60307</id>
<label>MAST3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-696162"/>
<interactant intactId="EBI-81196">
<id>Q9Y6Q9</id>
<label>NCOA3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-696162"/>
<interactant intactId="EBI-726944">
<id>P46934</id>
<label>NEDD4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-696162"/>
<interactant intactId="EBI-641237">
<id>P09619</id>
<label>PDGFRB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-696162"/>
<interactant intactId="EBI-357253">
<id>P62136</id>
<label>PPP1CA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-696162"/>
<interactant intactId="EBI-353193">
<id>Q06830</id>
<label>PRDX1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-696162"/>
<interactant intactId="EBI-349787">
<id>O14745</id>
<label>SLC9A3R1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-696162"/>
<interactant intactId="EBI-1149760">
<id>Q15599</id>
<label>SLC9A3R2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-696162"/>
<interactant intactId="EBI-538451">
<id>Q9JHL1</id>
<label>Slc9a3r2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-696162"/>
<interactant intactId="EBI-743549">
<id>O43791</id>
<label>SPOP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
<location>PML body</location>
</subcellularLocation>
<text>Monoubiquitinated form is nuclear. Nonubiquitinated form is cytoplasmic. Colocalized with PML and USP7 in PML nuclear bodies. XIAP/BIRC4 promotes its nuclear localization.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform alpha</molecule>
<subcellularLocation>
<location evidence="40 41">Secreted</location>
</subcellularLocation>
<text>May be secreted via a classical signal peptide and reenter into cells with the help of a poly-Arg motif.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<event type="alternative initiation"/>
<isoform>
<id>P60484-1</id>
<name>1</name>
<name>55kDa</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P60484-2</id>
<name>alpha</name>
<name>70kDa</name>
<name>PTEN-long</name>
<sequence type="described" ref="VSP_055420"/>
<text>Produced by alternative initiation at a CTG start codon of isoform 1. May contain a signal peptide at positions 1-21.</text>
</isoform>
<isoform>
<id>P60484-3</id>
<name>3</name>
<sequence type="described" ref="VSP_055421 VSP_055422 VSP_055423"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="43">Expressed at a relatively high level in all adult tissues, including heart, brain, placenta, lung, liver, muscle, kidney and pancreas.</text>
</comment>
<comment type="induction">
<text evidence="45">Down-regulated by TGFB1.</text>
</comment>
<comment type="domain">
<text evidence="14 15">The C2 domain binds phospholipid membranes in vitro in a Ca(2+)-independent manner; this binding is important for its tumor suppressor function.</text>
</comment>
<comment type="PTM">
<text evidence="16 22 25 29 31 32 35 36 39">Constitutively phosphorylated by CK2 under normal conditions. Phosphorylated in vitro by MAST1, MAST2, MAST3 and STK11. Phosphorylation results in an inhibited activity towards PIP3. Phosphorylation can both inhibit or promote PDZ-binding. Phosphorylation at Tyr-336 by FRK/PTK5 protects this protein from ubiquitin-mediated degradation probably by inhibiting its binding to NEDD4. Phosphorylation by ROCK1 is essential for its stability and activity. Phosphorylation by PLK3 promotes its stability and prevents its degradation by the proteasome.</text>
</comment>
<comment type="PTM">
<text evidence="35 37">Monoubiquitinated; monoubiquitination is increased in presence of retinoic acid. Deubiquitinated by USP7; leading to its nuclear exclusion. Monoubiquitination of one of either Lys-13 and Lys-289 amino acid is sufficient to modulate PTEN compartmentalization. Ubiquitinated by XIAP/BIRC4.</text>
</comment>
<comment type="disease" evidence="11 12 24 44 48 50 51 52 54 57 58 60 61">
<disease id="DI-01440">
<name>Cowden syndrome 1</name>
<acronym>CWS1</acronym>
<description>An autosomal dominant hamartomatous polyposis syndrome with age-related penetrance. Cowden syndrome is characterized by hamartomatous lesions affecting derivatives of ectodermal, mesodermal and endodermal layers, macrocephaly, facial trichilemmomas (benign tumors of the hair follicle infundibulum), acral keratoses, papillomatous papules, and elevated risk for development of several types of malignancy, particularly breast carcinoma in women and thyroid carcinoma in both men and women. Colon cancer and renal cell carcinoma have also been reported. Hamartomas can be found in virtually every organ, but most commonly in the skin, gastrointestinal tract, breast and thyroid.</description>
<dbReference type="MIM" id="158350"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<disease id="DI-01903">
<name>Lhermitte-Duclos disease</name>
<acronym>LDD</acronym>
<description>A rare disease characterized by the occurrence of a slowly enlarging mass within the cerebellar cortex corresponding histologically to a cerebellar hamartoma. It manifests, most commonly in the third and fourth decades of life, with increased intracranial pressure, headache, nausea, cerebellar dysfunction, occlusive hydrocephalus, ataxia, visual disturbances and other cranial nerve palsies. Various associated abnormalities may be present such as megalencephaly, microgyria, hydromyelia, polydactyly, partial gigantism, macroglossia. LDD is part of the PTEN hamartoma tumor syndromes spectrum that also includes Cowden syndrome.</description>
<dbReference type="MIM" id="158350"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="13 24 46 53">
<disease id="DI-01268">
<name>Bannayan-Riley-Ruvalcaba syndrome</name>
<acronym>BRRS</acronym>
<description>A rare hamartomatous disorder characterized by macrocephaly and multiple hemangiomas as well as subcutaneous and visceral lipomas. It belongs to the family of hamartomatous polyposis syndromes that includes Peutz Jeghers syndrome, juvenile polyposis, and Cowden syndrome.</description>
<dbReference type="MIM" id="153480"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="27">
<disease id="DI-01696">
<name>Squamous cell carcinoma of the head and neck</name>
<acronym>HNSCC</acronym>
<description>A non-melanoma skin cancer affecting the head and neck. The hallmark of cutaneous SCC is malignant transformation of normal epidermal keratinocytes.</description>
<dbReference type="MIM" id="275355"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<disease id="DI-01526">
<name>Endometrial cancer</name>
<acronym>ENDMC</acronym>
<description>A malignancy of endometrium, the mucous lining of the uterus. Most endometrial cancers are adenocarcinomas, cancers that begin in cells that make and release mucus and other fluids.</description>
<dbReference type="MIM" id="608089"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text>PTEN mutations are found in a subset of patients with Proteus syndrome, a genetically heterogeneous condition. The molecular diagnosis of PTEN mutation positive cases classifies Proteus syndrome patients as part of the PTEN hamartoma syndrome spectrum. As such, patients surviving the early years of Proteus syndrome are likely at a greater risk of developing malignancies.</text>
</comment>
<comment type="disease">
<disease id="DI-02567">
<name>Glioma 2</name>
<acronym>GLM2</acronym>
<description>Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes.</description>
<dbReference type="MIM" id="613028"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<disease id="DI-02408">
<name>VACTERL association with hydrocephalus</name>
<acronym>VACTERL-H</acronym>
<description>VACTERL is an acronym for vertebral anomalies, anal atresia, congenital cardiac disease, tracheoesophageal fistula, renal anomalies, radial dysplasia, and other limb defects.</description>
<dbReference type="MIM" id="276950"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="42">
<disease id="DI-02663">
<name>Prostate cancer</name>
<acronym>PC</acronym>
<description>A malignancy originating in tissues of the prostate. Most prostate cancers are adenocarcinomas that develop in the acini of the prostatic ducts. Other rare histopathologic types of prostate cancer that occur in approximately 5% of patients include small cell carcinoma, mucinous carcinoma, prostatic ductal carcinoma, transitional cell carcinoma, squamous cell carcinoma, basal cell carcinoma, adenoid cystic carcinoma (basaloid), signet-ring cell carcinoma and neuroendocrine carcinoma.</description>
<dbReference type="MIM" id="176807"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="30">
<disease id="DI-01924">
<name>Macrocephaly/autism syndrome</name>
<acronym>MCEPHAS</acronym>
<description>Patients have autism spectrum disorders and macrocephaly, with head circumferences ranging from +2.5 to +8 SD for age and sex (average head circumference +4.0 SD).</description>
<dbReference type="MIM" id="605309"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text>A microdeletion of chromosome 10q23 involving BMPR1A and PTEN is a cause of chromosome 10q23 deletion syndrome, which shows overlapping features of the following three disorders: Bannayan-Zonana syndrome, Cowden disease and juvenile polyposis syndrome.</text>
</comment>
<comment type="similarity">
<text evidence="9">Contains 1 C2 tensin-type domain.</text>
</comment>
<comment type="similarity">
<text evidence="10">Contains 1 phosphatase tensin-type domain.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/PTENID158.html"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/pten/"/>
</comment>
<dbReference type="EC" id="3.1.3.16"/>
<dbReference type="EC" id="3.1.3.48"/>
<dbReference type="EC" id="3.1.3.67"/>
<dbReference type="EMBL" id="U96180">
<property type="protein sequence ID" value="AAB66902.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U92436">
<property type="protein sequence ID" value="AAC51182.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U93051">
<property type="protein sequence ID" value="AAC51183.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF143315">
<property type="protein sequence ID" value="AAD38372.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF143312">
<property type="protein sequence ID" value="AAD38372.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF143313">
<property type="protein sequence ID" value="AAD38372.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF143314">
<property type="protein sequence ID" value="AAD38372.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF000734">
<property type="protein sequence ID" value="AAC08699.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF000726">
<property type="protein sequence ID" value="AAC08699.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF000727">
<property type="protein sequence ID" value="AAC08699.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF000728">
<property type="protein sequence ID" value="AAC08699.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF000729">
<property type="protein sequence ID" value="AAC08699.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF000730">
<property type="protein sequence ID" value="AAC08699.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF000731">
<property type="protein sequence ID" value="AAC08699.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF000732">
<property type="protein sequence ID" value="AAC08699.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF000733">
<property type="protein sequence ID" value="AAC08699.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF067844">
<property type="protein sequence ID" value="AAD13528.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="JF268690">
<property type="protein sequence ID" value="ADZ48535.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR450306">
<property type="protein sequence ID" value="CAG29302.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK313581">
<property type="protein sequence ID" value="BAG36351.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ073384">
<property type="protein sequence ID" value="AAY57327.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471066">
<property type="protein sequence ID" value="EAW50174.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC005821">
<property type="protein sequence ID" value="AAH05821.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS31238.1">
<molecule id="P60484-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000305.3">
<molecule id="P60484-1"/>
<property type="nucleotide sequence ID" value="NM_000314.6"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001291646.2">
<property type="nucleotide sequence ID" value="NM_001304717.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001291647.1">
<property type="nucleotide sequence ID" value="NM_001304718.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.500466"/>
<dbReference type="UniGene" id="Hs.729457"/>
<dbReference type="PDB" id="1D5R">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=8-353"/>
</dbReference>
<dbReference type="PDB" id="2KYL">
<property type="method" value="NMR"/>
<property type="chains" value="B=391-403"/>
</dbReference>
<dbReference type="PDB" id="4O1V">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="B=354-368"/>
</dbReference>
<dbReference type="PDB" id="5BUG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B/C/D=14-351"/>
</dbReference>
<dbReference type="PDB" id="5BZX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B/C/D=14-351"/>
</dbReference>
<dbReference type="PDB" id="5BZZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B/C/D=14-351"/>
</dbReference>
<dbReference type="PDBsum" id="1D5R"/>
<dbReference type="PDBsum" id="2KYL"/>
<dbReference type="PDBsum" id="4O1V"/>
<dbReference type="PDBsum" id="5BUG"/>
<dbReference type="PDBsum" id="5BZX"/>
<dbReference type="PDBsum" id="5BZZ"/>
<dbReference type="ProteinModelPortal" id="P60484"/>
<dbReference type="SMR" id="P60484">
<property type="residue range" value="14-351"/>
</dbReference>
<dbReference type="BioGrid" id="111700">
<property type="interactions" value="256"/>
</dbReference>
<dbReference type="DIP" id="DIP-35019N"/>
<dbReference type="IntAct" id="P60484">
<property type="interactions" value="51"/>
</dbReference>
<dbReference type="MINT" id="MINT-127351"/>
<dbReference type="STRING" id="9606.ENSP00000361021"/>
<dbReference type="BindingDB" id="P60484"/>
<dbReference type="ChEMBL" id="CHEMBL2052032"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2497"/>
<dbReference type="SwissLipids" id="SLP:000000849"/>
<dbReference type="DEPOD" id="P60484"/>
<dbReference type="iPTMnet" id="P60484"/>
<dbReference type="PhosphoSite" id="P60484"/>
<dbReference type="BioMuta" id="PTEN"/>
<dbReference type="DMDM" id="42560209"/>
<dbReference type="EPD" id="P60484"/>
<dbReference type="MaxQB" id="P60484"/>
<dbReference type="PaxDb" id="P60484"/>
<dbReference type="PRIDE" id="P60484"/>
<dbReference type="DNASU" id="5728"/>
<dbReference type="Ensembl" id="ENST00000371953">
<molecule id="P60484-1"/>
<property type="protein sequence ID" value="ENSP00000361021"/>
<property type="gene ID" value="ENSG00000171862"/>
</dbReference>
<dbReference type="GeneID" id="5728"/>
<dbReference type="KEGG" id="hsa:5728"/>
<dbReference type="UCSC" id="uc001kfb.4">
<molecule id="P60484-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5728"/>
<dbReference type="GeneCards" id="PTEN"/>
<dbReference type="GeneReviews" id="PTEN"/>
<dbReference type="HGNC" id="HGNC:9588">
<property type="gene designation" value="PTEN"/>
</dbReference>
<dbReference type="HPA" id="CAB004076"/>
<dbReference type="HPA" id="HPA031335"/>
<dbReference type="MalaCards" id="PTEN"/>
<dbReference type="MIM" id="137800">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="153480">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="158350">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="176807">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="275355">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="276950">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="601728">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="605309">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="608089">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="612242">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="613028">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P60484"/>
<dbReference type="Orphanet" id="109">
<property type="disease" value="Bannayan-Riley-Ruvalcaba syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="201">
<property type="disease" value="Cowden syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="145">
<property type="disease" value="Hereditary breast and ovarian cancer syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="79076">
<property type="disease" value="Juvenile polyposis of infancy"/>
</dbReference>
<dbReference type="Orphanet" id="65285">
<property type="disease" value="Lhermitte-Duclos disease"/>
</dbReference>
<dbReference type="Orphanet" id="210548">
<property type="disease" value="Macrocephaly-autism syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="744">
<property type="disease" value="Proteus syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="2969">
<property type="disease" value="Proteus-like syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="137608">
<property type="disease" value="Segmental outgrowth - lipomatosis - arteriovenous malformation - epidermal nevus"/>
</dbReference>
<dbReference type="Orphanet" id="67037">
<property type="disease" value="Squamous cell carcinoma of head and neck"/>
</dbReference>
<dbReference type="PharmGKB" id="PA33942"/>
<dbReference type="eggNOG" id="KOG2283">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG2453">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000119113"/>
<dbReference type="HOGENOM" id="HOG000008008"/>
<dbReference type="HOVERGEN" id="HBG000239"/>
<dbReference type="InParanoid" id="P60484"/>
<dbReference type="KO" id="K01110"/>
<dbReference type="OMA" id="YSPCESD"/>
<dbReference type="OrthoDB" id="EOG7R2BJ5"/>
<dbReference type="PhylomeDB" id="P60484"/>
<dbReference type="TreeFam" id="TF324513"/>
<dbReference type="BioCyc" id="MetaCyc:HS10404-MONOMER"/>
<dbReference type="BRENDA" id="3.1.3.16">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1660499">
<property type="pathway name" value="Synthesis of PIPs at the plasma membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1855204">
<property type="pathway name" value="Synthesis of IP3 and IP4 in the cytosol"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-199418">
<property type="pathway name" value="Negative regulation of the PI3K/AKT network"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-202424">
<property type="pathway name" value="Downstream TCR signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5674404">
<property type="pathway name" value="PTEN Loss of Function in Cancer"/>
</dbReference>
<dbReference type="SignaLink" id="P60484"/>
<dbReference type="ChiTaRS" id="PTEN">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P60484"/>
<dbReference type="GeneWiki" id="PTEN_(gene)"/>
<dbReference type="GenomeRNAi" id="5728"/>
<dbReference type="NextBio" id="20817328"/>
<dbReference type="PMAP-CutDB" id="P60484"/>
<dbReference type="PRO" id="PR:P60484"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 10"/>
</dbReference>
<dbReference type="Bgee" id="P60484"/>
<dbReference type="CleanEx" id="HS_PTEN"/>
<dbReference type="CleanEx" id="HS_TEP1"/>
<dbReference type="ExpressionAtlas" id="P60484">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P60484">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016324">
<property type="term" value="C:apical plasma membrane"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042995">
<property type="term" value="C:cell projection"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009898">
<property type="term" value="C:cytoplasmic side of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043197">
<property type="term" value="C:dendritic spine"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035749">
<property type="term" value="C:myelin sheath adaxonal region"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043005">
<property type="term" value="C:neuron projection"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016605">
<property type="term" value="C:PML body"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0045211">
<property type="term" value="C:postsynaptic membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043220">
<property type="term" value="C:Schmidt-Lanterman incisure"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010997">
<property type="term" value="F:anaphase-promoting complex binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0051717">
<property type="term" value="F:inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008289">
<property type="term" value="F:lipid binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0000287">
<property type="term" value="F:magnesium ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0030165">
<property type="term" value="F:PDZ domain binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016314">
<property type="term" value="F:phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051800">
<property type="term" value="F:phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004438">
<property type="term" value="F:phosphatidylinositol-3-phosphatase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004721">
<property type="term" value="F:phosphoprotein phosphatase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004722">
<property type="term" value="F:protein serine/threonine phosphatase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004725">
<property type="term" value="F:protein tyrosine phosphatase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008138">
<property type="term" value="F:protein tyrosine/serine/threonine phosphatase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0007092">
<property type="term" value="P:activation of APC-Cdc20 complex activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030534">
<property type="term" value="P:adult behavior"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007568">
<property type="term" value="P:aging"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001525">
<property type="term" value="P:angiogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048854">
<property type="term" value="P:brain morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060070">
<property type="term" value="P:canonical Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048738">
<property type="term" value="P:cardiac muscle tissue development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016477">
<property type="term" value="P:cell migration"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071456">
<property type="term" value="P:cellular response to hypoxia"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007417">
<property type="term" value="P:central nervous system development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032286">
<property type="term" value="P:central nervous system myelin maintenance"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0021955">
<property type="term" value="P:central nervous system neuron axonogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060997">
<property type="term" value="P:dendritic spine morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0021542">
<property type="term" value="P:dentate gyrus development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043542">
<property type="term" value="P:endothelial cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007173">
<property type="term" value="P:epidermal growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0038095">
<property type="term" value="P:Fc-epsilon receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008543">
<property type="term" value="P:fibroblast growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048853">
<property type="term" value="P:forebrain morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007507">
<property type="term" value="P:heart development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046855">
<property type="term" value="P:inositol phosphate dephosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043647">
<property type="term" value="P:inositol phosphate metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007611">
<property type="term" value="P:learning or memory"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045475">
<property type="term" value="P:locomotor rhythm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007626">
<property type="term" value="P:locomotory behavior"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060292">
<property type="term" value="P:long term synaptic depression"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060291">
<property type="term" value="P:long-term synaptic potentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060179">
<property type="term" value="P:male mating behavior"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042711">
<property type="term" value="P:maternal behavior"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007613">
<property type="term" value="P:memory"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033555">
<property type="term" value="P:multicellular organismal response to stress"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050771">
<property type="term" value="P:negative regulation of axonogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090344">
<property type="term" value="P:negative regulation of cell aging"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030336">
<property type="term" value="P:negative regulation of cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045792">
<property type="term" value="P:negative regulation of cell size"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031658">
<property type="term" value="P:negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0061002">
<property type="term" value="P:negative regulation of dendritic spine morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050680">
<property type="term" value="P:negative regulation of epithelial cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070373">
<property type="term" value="P:negative regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090394">
<property type="term" value="P:negative regulation of excitatory postsynaptic potential"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051895">
<property type="term" value="P:negative regulation of focal adhesion assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000134">
<property type="term" value="P:negative regulation of G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031642">
<property type="term" value="P:negative regulation of myelination"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046621">
<property type="term" value="P:negative regulation of organ growth"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050765">
<property type="term" value="P:negative regulation of phagocytosis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0014067">
<property type="term" value="P:negative regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051898">
<property type="term" value="P:negative regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001933">
<property type="term" value="P:negative regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090071">
<property type="term" value="P:negative regulation of ribosome biogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000808">
<property type="term" value="P:negative regulation of synaptic vesicle clustering"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007270">
<property type="term" value="P:neuron-neuron synaptic transmission"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048011">
<property type="term" value="P:neurotrophin TRK receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035335">
<property type="term" value="P:peptidyl-tyrosine dephosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0006661">
<property type="term" value="P:phosphatidylinositol biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046856">
<property type="term" value="P:phosphatidylinositol dephosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048015">
<property type="term" value="P:phosphatidylinositol-mediated signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006644">
<property type="term" value="P:phospholipid metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048008">
<property type="term" value="P:platelet-derived growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000463">
<property type="term" value="P:positive regulation of excitatory postsynaptic potential"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000060">
<property type="term" value="P:positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051091">
<property type="term" value="P:positive regulation of sequence-specific DNA binding transcription factor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903984">
<property type="term" value="P:positive regulation of TRAIL-activated apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097107">
<property type="term" value="P:postsynaptic density assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060134">
<property type="term" value="P:prepulse inhibition"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097105">
<property type="term" value="P:presynaptic membrane assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060736">
<property type="term" value="P:prostate gland growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006470">
<property type="term" value="P:protein dephosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043491">
<property type="term" value="P:protein kinase B signaling"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050821">
<property type="term" value="P:protein stabilization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048679">
<property type="term" value="P:regulation of axon regeneration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002902">
<property type="term" value="P:regulation of B cell apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032535">
<property type="term" value="P:regulation of cellular component size"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000079">
<property type="term" value="P:regulation of cyclin-dependent protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033032">
<property type="term" value="P:regulation of myeloid cell apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010975">
<property type="term" value="P:regulation of neuron projection development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031647">
<property type="term" value="P:regulation of protein stability"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032228">
<property type="term" value="P:regulation of synaptic transmission, GABAergic"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046685">
<property type="term" value="P:response to arsenic-containing substance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033198">
<property type="term" value="P:response to ATP"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032355">
<property type="term" value="P:response to estradiol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045471">
<property type="term" value="P:response to ethanol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009749">
<property type="term" value="P:response to glucose"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007584">
<property type="term" value="P:response to nutrient"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010043">
<property type="term" value="P:response to zinc ion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060024">
<property type="term" value="P:rhythmic synaptic transmission"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0044281">
<property type="term" value="P:small molecule metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035176">
<property type="term" value="P:social behavior"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007416">
<property type="term" value="P:synapse assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060074">
<property type="term" value="P:synapse maturation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050852">
<property type="term" value="P:T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="Gene3D" id="3.90.190.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR017361">
<property type="entry name" value="Bifunc_PIno_P3_Pase/Pase_PTEN"/>
</dbReference>
<dbReference type="InterPro" id="IPR000008">
<property type="entry name" value="C2_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000340">
<property type="entry name" value="Dual-sp_phosphatase_cat-dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR029021">
<property type="entry name" value="Prot-tyrosine_phosphatase-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR014020">
<property type="entry name" value="Tensin_C2-dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR029023">
<property type="entry name" value="Tensin_lipid_phosphatase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR016130">
<property type="entry name" value="Tyr_Pase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00782">
<property type="entry name" value="DSPc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF10409">
<property type="entry name" value="PTEN_C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF038025">
<property type="entry name" value="PTEN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49562">
<property type="entry name" value="SSF49562"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52799">
<property type="entry name" value="SSF52799"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51182">
<property type="entry name" value="C2_TENSIN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51181">
<property type="entry name" value="PPASE_TENSIN"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0024">Alternative initiation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-1268">Autism spectrum disorder</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0443">Lipid metabolism</keyword>
<keyword id="KW-0446">Lipid-binding</keyword>
<keyword id="KW-0524">Neurogenesis</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0904">Protein phosphatase</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="5">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN" id="PRO_0000215904">
<location>
<begin position="2"/>
<end position="403"/>
</location>
</feature>
<feature type="domain" description="Phosphatase tensin-type" evidence="10">
<location>
<begin position="14"/>
<end position="185"/>
</location>
</feature>
<feature type="domain" description="C2 tensin-type" evidence="9">
<location>
<begin position="190"/>
<end position="350"/>
</location>
</feature>
<feature type="region of interest" description="PDZ domain-binding">
<location>
<begin position="401"/>
<end position="403"/>
</location>
</feature>
<feature type="active site" description="Phosphocysteine intermediate" evidence="10">
<location>
<position position="124"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylthreonine" evidence="5">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="294"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by FRK" evidence="36">
<location>
<position position="336"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by GSK3-beta and PLK3" evidence="6 29 39">
<location>
<position position="366"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK2 and PLK3" evidence="22 29 39">
<location>
<position position="370"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by ROCK1 and CK2" evidence="22">
<location>
<position position="380"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by ROCK1 and CK2" evidence="22">
<location>
<position position="382"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by ROCK1 and CK2" evidence="22">
<location>
<position position="383"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK2" evidence="22 29">
<location>
<position position="385"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="16">
<location>
<position position="401"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="35">
<location>
<position position="13"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="35">
<location>
<position position="289"/>
</location>
</feature>
<feature type="splice variant" description="In isoform alpha." id="VSP_055420" evidence="64">
<original>M</original>
<variation>MERGGEAAAAAAAAAAAPGRGSESPVTISRAGNAGELVSPLLLPPTRRRRRRHIQGPGPVLNLPSAAAAPPVARAPEAAGGGSRSEDYSSSPHSAAAAARPLAAEEKQAQSLQPSSSRRSSHYPAAVQSQAAAERGASATAKSRAISILQKKPRHQQLLPSLSSFFFSHRLPDM</variation>
<location>
<position position="1"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_055421" evidence="63">
<original>RFLDSKHKNHYKIYNL</original>
<variation>S</variation>
<location>
<begin position="55"/>
<end position="70"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_055422" evidence="63">
<original>GVTIPSQRRYVYYYSYLLKNHLDYRP</original>
<variation>ADPTGGIPDKGIIVIGDGSSMDVIAP</variation>
<location>
<begin position="165"/>
<end position="190"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_055423" evidence="63">
<location>
<begin position="191"/>
<end position="403"/>
</location>
</feature>
<feature type="sequence variant" description="Retains phosphatase activity towards Ins(1,3,4,5)P4 and PtdIns(3,4,5)P3; retains the ability to bind phospholipid membranes." id="VAR_026248" evidence="20">
<original>S</original>
<variation>N</variation>
<location>
<position position="10"/>
</location>
</feature>
<feature type="sequence variant" description="In glioma." id="VAR_007457" evidence="43">
<original>R</original>
<variation>S</variation>
<location>
<position position="15"/>
</location>
</feature>
<feature type="sequence variant" description="Loss of phosphatase activity towards Ins(1,3,4,5)P4; retains the ability to bind phospholipid membranes." id="VAR_026249" evidence="20">
<original>Y</original>
<variation>C</variation>
<location>
<position position="16"/>
</location>
</feature>
<feature type="sequence variant" description="In malignant melanoma; somatic mutation." id="VAR_018100" evidence="21">
<original>D</original>
<variation>N</variation>
<location>
<position position="19"/>
</location>
</feature>
<feature type="sequence variant" description="Reduced phosphatase activity towards Ins(1,3,4,5)P4; retains phosphatase activity towards PtdIns(3,4,5)P3." id="VAR_026250" evidence="20">
<original>G</original>
<variation>E</variation>
<location>
<position position="20"/>
</location>
</feature>
<feature type="sequence variant" description="Loss of phosphatase activity towards Ins(1,3,4,5)P4." id="VAR_026251" evidence="20">
<original>Y</original>
<variation>S</variation>
<location>
<position position="27"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1." id="VAR_008733" evidence="12">
<location>
<position position="33"/>
</location>
</feature>
<feature type="sequence variant" description="In BRRS." id="VAR_008734" evidence="13 24">
<original>A</original>
<variation>D</variation>
<location>
<position position="34"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1." id="VAR_008036" evidence="52">
<original>M</original>
<variation>R</variation>
<location>
<position position="35"/>
</location>
</feature>
<feature type="sequence variant" description="In glioma." id="VAR_007458" evidence="43">
<original>G</original>
<variation>E</variation>
<location>
<position position="36"/>
</location>
</feature>
<feature type="sequence variant" description="In endometrial hyperplasia." id="VAR_026252" evidence="56">
<original>G</original>
<variation>R</variation>
<location>
<position position="36"/>
</location>
</feature>
<feature type="sequence variant" description="In glioma; retains phosphatase activity towards Ins(1,3,4,5)P4 and PtdIns(3,4,5)P3; retains the ability to bind phospholipid membranes." id="VAR_007459" evidence="43">
<original>L</original>
<variation>R</variation>
<location>
<position position="42"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1." id="VAR_011587" evidence="24">
<original>R</original>
<variation>G</variation>
<location>
<position position="47"/>
</location>
</feature>
<feature type="sequence variant" description="In glioma; loss of protein phosphatase activity." id="VAR_007460" evidence="43 47">
<original>L</original>
<variation>W</variation>
<location>
<position position="57"/>
</location>
</feature>
<feature type="sequence variant" description="In VATER." id="VAR_018101" evidence="26">
<original>H</original>
<variation>D</variation>
<location>
<position position="61"/>
</location>
</feature>
<feature type="sequence variant" description="Loss of phosphatase activity towards Ins(1,3,4,5)P4." id="VAR_026253" evidence="20">
<original>H</original>
<variation>R</variation>
<location>
<position position="61"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1." id="VAR_007461">
<original>I</original>
<variation>R</variation>
<location>
<position position="67"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1 and BRRS; loss of phosphatase activity towards Ins(1,3,4,5)P4 and PtdIns(3,4,5)P3; retains the ability to bind phospholipid membranes." id="VAR_007462" evidence="13 20 24 54">
<original>Y</original>
<variation>H</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1." id="VAR_018102" evidence="60">
<original>L</original>
<variation>P</variation>
<location>
<position position="70"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1; loss of phosphatase activity towards Ins(1,3,4,5)P4." id="VAR_026254" evidence="20">
<original>C</original>
<variation>Y</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="sequence variant" description="In MCEPHAS." id="VAR_032634" evidence="30">
<original>H</original>
<variation>R</variation>
<location>
<position position="93"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1." id="VAR_026255" evidence="20">
<original>H</original>
<variation>Y</variation>
<location>
<position position="93"/>
</location>
</feature>
<feature type="sequence variant" description="In BRRS; loss of phosphatase activity towards Ins(1,3,4,5)P4." id="VAR_026256" evidence="20">
<original>C</original>
<variation>F</variation>
<location>
<position position="105"/>
</location>
</feature>
<feature type="sequence variant" description="In BRRS." id="VAR_008735" evidence="13 24">
<original>C</original>
<variation>Y</variation>
<location>
<position position="105"/>
</location>
</feature>
<feature type="sequence variant" description="In BRRS and glioblastoma; loss of phosphatase activity towards Ins(1,3,4,5)P4." id="VAR_026257" evidence="20 49">
<original>D</original>
<variation>Y</variation>
<location>
<position position="107"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1 and LDD; loss of phosphatase activity towards Ins(1,3,4,5)P4." id="VAR_007807" evidence="11 20 54">
<original>L</original>
<variation>P</variation>
<location>
<position position="112"/>
</location>
</feature>
<feature type="sequence variant" description="Loss of phosphatase activity towards Ins(1,3,4,5)P4." id="VAR_026258" evidence="20">
<original>L</original>
<variation>R</variation>
<location>
<position position="112"/>
</location>
</feature>
<feature type="sequence variant" description="In multiple cancers." id="VAR_011588" evidence="19">
<original>V</original>
<variation>L</variation>
<location>
<position position="119"/>
</location>
</feature>
<feature type="sequence variant" description="In HNSCC." id="VAR_018103" evidence="27">
<original>A</original>
<variation>G</variation>
<location>
<position position="121"/>
</location>
</feature>
<feature type="sequence variant" description="In glioblastoma; loss of phosphatase activity towards Ins(1,3,4,5)P4." id="VAR_026259" evidence="20 49">
<original>A</original>
<variation>P</variation>
<location>
<position position="121"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1." id="VAR_007463" evidence="12 48">
<original>H</original>
<variation>R</variation>
<location>
<position position="123"/>
</location>
</feature>
<feature type="sequence variant" description="In endometrial cancer; loss of protein phosphatase activity." id="VAR_026260" evidence="47">
<original>H</original>
<variation>Y</variation>
<location>
<position position="123"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1." id="VAR_007464" evidence="12 20 48">
<original>C</original>
<variation>R</variation>
<location>
<position position="124"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1; phosphatase-dead protein with neither lipid nor protein phosphatase activity." id="VAR_018104" evidence="23 59">
<original>C</original>
<variation>S</variation>
<location>
<position position="124"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1; no lipid phosphatase activity but retains protein phosphatase activity; retains ability to inhibit focal adhesion formation." id="VAR_007465" evidence="20 23 44 55 59">
<original>G</original>
<variation>E</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="sequence variant" description="In glioblastoma; severely reduced protein phosphatase activity; loss of phosphatase activity towards Ins(1,3,4,5)P4." id="VAR_007466" evidence="20 42 47 49">
<original>G</original>
<variation>R</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="sequence variant" description="Loss of phosphatase activity towards Ins(1,3,4,5)P4 and PtdIns(3,4,5)P3." id="VAR_026261" evidence="20">
<original>R</original>
<variation>G</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1 and endometrial hyperplasia; loss of phosphatase activity towards Ins(1,3,4,5)P4; retains ability to bind phospholipid membranes." id="VAR_007467" evidence="20 56">
<original>R</original>
<variation>L</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1; loss of phosphatase activity towards Ins(1,3,4,5)P4; retains ability to bind phospholipid membranes." id="VAR_007468" evidence="20 61">
<original>R</original>
<variation>Q</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="sequence variant" description="In one patient with clinical findings suggesting hamartoma tumor syndrome." id="VAR_032635" evidence="33">
<original>G</original>
<variation>V</variation>
<location>
<position position="132"/>
</location>
</feature>
<feature type="sequence variant" description="Loss of phosphatase activity towards Ins(1,3,4,5)P3." id="VAR_026262" evidence="20">
<original>V</original>
<variation>I</variation>
<location>
<position position="133"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; no effect on protein phosphatase activity; reduced phosphatase activity towards Ins(1,3,4,5)P3 but retains PtdIns(3,4,5)P3 phosphatase activity." id="VAR_007469" evidence="20 42 47">
<original>M</original>
<variation>L</variation>
<location>
<position position="134"/>
</location>
</feature>
<feature type="sequence variant" description="In BRRS." id="VAR_008736" evidence="13 24">
<original>I</original>
<variation>V</variation>
<location>
<position position="135"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1; loss of phosphatase activity towards Ins(1,3,4,5)P3." id="VAR_007808" evidence="20 57">
<original>C</original>
<variation>Y</variation>
<location>
<position position="136"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1." id="VAR_008737" evidence="50">
<original>A</original>
<variation>AN</variation>
<location>
<position position="137"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1; loss of phosphatase activity towards Ins(1,3,4,5)P4." id="VAR_026263" evidence="20">
<original>Y</original>
<variation>C</variation>
<location>
<position position="155"/>
</location>
</feature>
<feature type="sequence variant" description="In multiple cancers." id="VAR_011589" evidence="19">
<original>V</original>
<variation>L</variation>
<location>
<position position="158"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1." id="VAR_008739" evidence="12">
<original>G</original>
<variation>E</variation>
<location>
<position position="165"/>
</location>
</feature>
<feature type="sequence variant" description="In glioblastoma; severely reduced protein phosphatase activity; loss of phosphatase activity towards Ins(1,3,4,5)P4; retains ability to bind phospholipid membranes." id="VAR_026264" evidence="20 47 49">
<original>G</original>
<variation>R</variation>
<location>
<position position="165"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1." id="VAR_008738">
<original>G</original>
<variation>V</variation>
<location>
<position position="165"/>
</location>
</feature>
<feature type="sequence variant" description="In breast cancer; severely reduced protein phosphatase activity." id="VAR_026265" evidence="47">
<original>T</original>
<variation>P</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="sequence variant" description="Loss of phosphatase activity towards Ins(1,3,4,5)P4; retains ability to bind phospholipid membranes." id="VAR_026266" evidence="20">
<original>S</original>
<variation>N</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In BRRS; severely reduced protein phosphatase activity; loss of phosphatase activity towards Ins(1,3,4,5)P4." id="VAR_007470" evidence="13 20 24 46 47">
<original>S</original>
<variation>R</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In endometrial hyperplasia; loss of phosphatase activity towards Ins(1,3,4,5)P4 and PtdIns(3,4,5)P3; retains ability to bind phospholipid membranes." id="VAR_026267" evidence="20 56">
<original>R</original>
<variation>C</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="sequence variant" description="Loss of phosphatase activity towards Ins(1,3,4,5)P4." id="VAR_026268" evidence="20">
<original>R</original>
<variation>H</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="sequence variant" description="Loss of phosphatase activity towards Ins(1,3,4,5)P4." id="VAR_026269" evidence="20">
<original>R</original>
<variation>P</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="sequence variant" description="Loss of phosphatase activity towards Ins(1,3,4,5)P4." id="VAR_026270" evidence="20">
<original>Y</original>
<variation>N</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="sequence variant" description="In endometrial hyperplasia." id="VAR_026271" evidence="56">
<original>V</original>
<variation>A</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="sequence variant" description="In malignant melanoma; somatic mutation." id="VAR_018105" evidence="21">
<original>V</original>
<variation>I</variation>
<location>
<position position="217"/>
</location>
</feature>
<feature type="sequence variant" description="Reduced phosphatase activity towards Ins(1,3,4,5)P4 but retains PtdIns(3,4,5)P3 phosphatase activity." id="VAR_026272" evidence="20">
<original>S</original>
<variation>F</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence variant" description="In GLM2; the patient also suffered from benign meningioma; not capable of inducing apoptosis; induced increased cell proliferation; led to high constitutive AKT1 activation which could not be increased further by stimulation with insulin." id="VAR_018106" evidence="28">
<original>R</original>
<variation>Q</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="sequence variant" description="In MCEPHAS." id="VAR_032636" evidence="30">
<original>F</original>
<variation>S</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1 and BRRS." id="VAR_008740" evidence="13">
<original>P</original>
<variation>L</variation>
<location>
<position position="246"/>
</location>
</feature>
<feature type="sequence variant" description="Loss of phosphatase activity towards Ins(1,3,4,5)P4; retains ability to bind phospholipid membranes." id="VAR_026273" evidence="20">
<original>G</original>
<variation>C</variation>
<location>
<position position="251"/>
</location>
</feature>
<feature type="sequence variant" description="In MCEPHAS." id="VAR_032637" evidence="30">
<original>D</original>
<variation>G</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1; reduced phosphatase activity towards Ins(1,3,4,5)P4; retains ability to bind phospholipid membranes." id="VAR_008741" evidence="20 58">
<original>K</original>
<variation>E</variation>
<location>
<position position="289"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35600253." id="VAR_025167" evidence="62">
<original>V</original>
<variation>L</variation>
<location>
<position position="290"/>
</location>
</feature>
<feature type="sequence variant" description="In glioma; reduced tumor suppressor activity; fails to inactivate AKT/PKB." id="VAR_026274" evidence="14 43">
<location>
<position position="319"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1; reduced phosphatase activity towards Ins(1,3,4,5)P4; retains ability to bind phospholipid membranes." id="VAR_026275" evidence="20">
<original>D</original>
<variation>G</variation>
<location>
<position position="331"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1; loss of phosphatase activity towards Ins(1,3,4,5)P4." id="VAR_026276" evidence="20">
<original>F</original>
<variation>V</variation>
<location>
<position position="341"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1; reduced phosphatase activity towards Ins(1,3,4,5)P4 but PtdIns(3,4,5)P3 phosphatase activity is similar to wild-type." id="VAR_026277" evidence="20">
<original>K</original>
<variation>N</variation>
<location>
<position position="342"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1; loss of phosphatase activity towards Ins(1,3,4,5)P4." id="VAR_008742" evidence="20 51">
<original>V</original>
<variation>E</variation>
<location>
<position position="343"/>
</location>
</feature>
<feature type="sequence variant" description="In glioblastoma; reduced tumor suppressor activity; loss of phosphatase activity towards Ins(1,3,4,5)P4; reduced ability to inactivate AKT/PKB; retains ability to bind phospholipid membranes." id="VAR_026278" evidence="14 20 49">
<original>L</original>
<variation>Q</variation>
<location>
<position position="345"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS1; reduced phosphatase activity towards Ins(1,3,4,5)P4." id="VAR_008743" evidence="20 51">
<original>F</original>
<variation>L</variation>
<location>
<position position="347"/>
</location>
</feature>
<feature type="sequence variant" description="In endometrial hyperplasia; reduced phosphatase activity towards PtdIns(3,4,5)P3; mildly reduced tumor suppressor activity; reduced ability to inactivate AKT/PKB." id="VAR_026279" evidence="14 56">
<original>T</original>
<variation>I</variation>
<location>
<position position="348"/>
</location>
</feature>
<feature type="sequence variant" description="Retains Ins(1,3,4,5)P4 and PtdIns(3,4,5)P3 phosphatase activity; retains ability to bind phospholipid membranes." id="VAR_026280" evidence="20">
<original>V</original>
<variation>G</variation>
<location>
<position position="369"/>
</location>
</feature>
<feature type="sequence variant" description="Retains Ins(1,3,4,5)P4 and PtdIns(3,4,5)P3 phosphatase activity; retains ability to bind phospholipid membranes." id="VAR_026281" evidence="20">
<original>T</original>
<variation>I</variation>
<location>
<position position="401"/>
</location>
</feature>
<feature type="mutagenesis site" description="Expression is restricted to isoform alpha." evidence="41">
<original>M</original>
<variation>I</variation>
<location>
<position position="1"/>
</location>
</feature>
<feature type="mutagenesis site" description="Nuclear. Cytoplasmic; when associated with E-289. Shows less tumor suppressive ability; when associated with E-289." evidence="35">
<original>K</original>
<variation>E</variation>
<location>
<position position="13"/>
</location>
</feature>
<feature type="mutagenesis site" description="700-fold reduction in phosphatase activity towards PtdIns(3,4,5)P3. Loss of protein phosphatase activity. Unable to inhibit focal adhesion formation." evidence="15 55">
<original>D</original>
<variation>A</variation>
<location>
<position position="92"/>
</location>
</feature>
<feature type="mutagenesis site" description="75% reduction in phosphatase activity towards PtdIns(3,4,5)P3. Modest reduction in phosphatase activity towards PtdIns(3,4)P2." evidence="15">
<original>H</original>
<variation>A</variation>
<location>
<position position="93"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of protein phosphatase activity. Unable to inhibit focal adhesion formation." evidence="55">
<original>C</original>
<variation>A</variation>
<location>
<position position="124"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced phosphatase activity towards PtdIns(3,4,5)P3, PtdIns(3,4)P2 and PtdIns(3)P." evidence="15">
<original>K</original>
<variation>M</variation>
<location>
<position position="125"/>
</location>
</feature>
<feature type="mutagenesis site" description="85% reduction in phosphatase activity towards PtdIns(3,4,5)P3." evidence="15">
<original>K</original>
<variation>M</variation>
<location>
<position position="128"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not reduce phosphatase activity towards PtdIns(3,4,5)P3." evidence="15">
<original>K</original>
<variation>R</variation>
<location>
<position position="128"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect the ability to inhibit AKT/PKB activation." evidence="59">
<original>R</original>
<variation>M</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="mutagenesis site" description="60% reduction in phosphatase activity towards PtdIns(3,4,5)P3." evidence="15">
<original>T</original>
<variation>A</variation>
<variation>D</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="mutagenesis site" description="75% reduction in phosphatase activity towards PtdIns(3,4,5)P3." evidence="15">
<original>Q</original>
<variation>A</variation>
<variation>E</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces the growth suppression activity and cells show anchorage-independent growth. Reduces binding to phospholipid membranes in vitro. Phosphatase activity towards PtdIns(3,4,5)P3 is not affected." evidence="15">
<original>KMLKKDK</original>
<variation>AAGAADA</variation>
<location>
<begin position="263"/>
<end position="269"/>
</location>
</feature>
<feature type="mutagenesis site" description="Nuclear. Cytoplasmic; when associated with E-13. Shows less tumor suppressive ability; when associated with E-13." evidence="35">
<original>K</original>
<variation>E</variation>
<location>
<position position="289"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces growth suppression activity and promotes anchorage-independent growth. Reduces binding to phospholipid membranes in vitro; phosphatase activity towards PtdIns(3,4,5)P3 is not affected." evidence="15">
<original>KANKDKANR</original>
<variation>AAGADAANA</variation>
<location>
<begin position="327"/>
<end position="335"/>
</location>
</feature>
<feature type="mutagenesis site" description="Significantly lower phosphatase activity, reduced protein stability and decreased growth-inhibitory effect." evidence="36">
<original>Y</original>
<variation>F</variation>
<location>
<position position="336"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased stability." evidence="39">
<original>T</original>
<variation>A</variation>
<location>
<position position="366"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased stability." evidence="39">
<original>S</original>
<variation>A</variation>
<location>
<position position="370"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of DLG1-binding. No effect on MAGI2- and MAST2-binding.">
<original>T</original>
<variation>A</variation>
<location>
<position position="401"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on MAGI2-, MAST2- and DLG1-binding.">
<original>K</original>
<variation>A</variation>
<location>
<position position="402"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of DLG1-, MAGI2-, MAGI3- and MAST2-binding. Decrease of protein stability.">
<original>K</original>
<variation>W</variation>
<location>
<position position="402"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of DLG1-, MAGI2-, MAGI3-, MAST1-, MAST2- and MAST3-binding." evidence="31">
<original>V</original>
<variation>A</variation>
<location>
<position position="403"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="19"/>
<end position="22"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="23"/>
<end position="29"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="32"/>
<end position="35"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="39"/>
<end position="41"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="44"/>
<end position="47"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="50"/>
<end position="60"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="61"/>
<end position="63"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="65"/>
<end position="73"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="78"/>
<end position="80"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="81"/>
<end position="83"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="85"/>
<end position="90"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="98"/>
<end position="100"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="101"/>
<end position="112"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="113"/>
<end position="115"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="118"/>
<end position="123"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="125"/>
<end position="128"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="129"/>
<end position="141"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="148"/>
<end position="159"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="161"/>
<end position="163"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="169"/>
<end position="184"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="192"/>
<end position="202"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="206"/>
<end position="209"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="213"/>
<end position="219"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="222"/>
<end position="226"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="232"/>
<end position="235"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="238"/>
<end position="259"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="262"/>
<end position="264"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="268"/>
<end position="276"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="277"/>
<end position="279"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="280"/>
<end position="284"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="310"/>
<end position="312"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="315"/>
<end position="321"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="322"/>
<end position="324"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="328"/>
<end position="330"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="335"/>
<end position="337"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="342"/>
<end position="349"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="395"/>
<end position="403"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1D5R"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2KYL"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5BZX"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5BZZ"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250"/>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O08586"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00589"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00590"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10051160"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10234502"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10400993"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10468583"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10555148"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10646847"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10748157"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10760291"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10807691"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10866302"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10978354"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11035045"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11230179"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11494117"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11707428"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11748304"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11801303"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12085208"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12297295"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15805158"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15951562"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15987703"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16752378"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17218260"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18716620"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19345329"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19473982"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20534535"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20940307"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23744781"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24768297"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9072974"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9090379"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9140396"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9187108"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9241266"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9256433"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9259288"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9331071"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9345101"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9399897"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9425889"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9467011"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9600246"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9616126"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9635567"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9735393"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9797362"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9811831"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9832031"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9915974"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source ref="10"/>
</evidence>
<evidence key="63" type="ECO:0000303">
<source ref="7"/>
</evidence>
<evidence key="64" type="ECO:0000305"/>
<sequence length="403" mass="47166" checksum="75F97C3DD6802BA9" modified="2004-02-16" version="1">
MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSK
HKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVA
AIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSY
LLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMY
FEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEI
DSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEAS
SSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>